132 related articles for article (PubMed ID: 28174388)
1. [A Case of Renal Cell Carcinoma with High Everolimus Blood Concentrations and Hyperglycemia Due to Everolimus-Induced Hepatic Dysfunction].
Takasaki S; Kikuchi M; Kawasaki Y; Ito A; Arai Y; Yamaguchi H; Mano N
Gan To Kagaku Ryoho; 2017 Jan; 44(1):87-89. PubMed ID: 28174388
[TBL] [Abstract][Full Text] [Related]
2. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].
Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128
[TBL] [Abstract][Full Text] [Related]
3. [Spontaneous Remission of Everolimus-Induced Interstitial Lung Disease in Metastatic Renal Cell Carcinoma : An Autopsy Case Report].
Kurokawa M; Naito S; Ichiyanagi O; Kabasawa T; Kurota Y; Sakurai T; Nishida H; Kawazoe H; Kato T; Nagaoka A; Yamakawa M; Tsuchiya N
Hinyokika Kiyo; 2017 Sep; 63(9):377-380. PubMed ID: 28992668
[TBL] [Abstract][Full Text] [Related]
4. Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature.
Detti B; Francolini G; Becherini C; Olmetto E; Giacomelli I; Scartoni D; Greto D; Baldazzi V; Simontacchi G; Meattini I; Livi L
J Chemother; 2016 Oct; 28(5):432-4. PubMed ID: 27376403
[TBL] [Abstract][Full Text] [Related]
5. Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report.
Komatsu H; Izumi N; Tsukioka T; Toda M; Hara K; Miyamoto H; Nishiyama N
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):151-153. PubMed ID: 29249770
[TBL] [Abstract][Full Text] [Related]
6. Adverse event profile and dose modification of everolimus for advanced renal cell carcinoma in real-world Japanese clinical practice.
Nozawa M; Nonomura N; Ueda T; Nishimura K; Kanayama HO; Miki T; Nakatani T; Tomita Y; Azuma H; Yoshioka T; Tsujihata M; Uemura H
Jpn J Clin Oncol; 2013 Nov; 43(11):1132-8. PubMed ID: 23999768
[TBL] [Abstract][Full Text] [Related]
7. TSC1/2 mutations as markers of response to everolimus in metastatic renal cell carcinoma: A case study.
Jacob LA; Shafi G
Indian J Cancer; 2019; 56(3):274-275. PubMed ID: 31389395
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.
Bono P; Oudard S; Bodrogi I; Hutson TE; Escudier B; Machiels JP; Thompson JA; Figlin RA; Ravaud A; Basaran M; Porta C; Bracarda S; Brechenmacher T; Lin C; Voi M; Grunwald V; Motzer RJ
Clin Genitourin Cancer; 2016 Oct; 14(5):406-414. PubMed ID: 27287020
[TBL] [Abstract][Full Text] [Related]
9. Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: results of a pooled analysis of non-interventional studies.
Albiges L; Kube U; Eymard JC; Schmidinger M; Bamias A; Kelkouli N; Mraz B; Florini S; Guderian G; Cattaneo A; Bergmann L
Eur J Cancer; 2015 Nov; 51(16):2368-74. PubMed ID: 26276039
[TBL] [Abstract][Full Text] [Related]
10. A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer.
Lolli C; Gallà V; Schepisi G; Barone D; Burgio SL; Maugeri A; Vertogen B; Amadori D; De Giorgi U
Oncologist; 2017 Jul; 22(7):784-e74. PubMed ID: 28546463
[TBL] [Abstract][Full Text] [Related]
11. Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.
Akaza H; Kurihara R; Katsura A; Harumiya M; Ushida N
Jpn J Clin Oncol; 2019 Oct; 49(10):956-964. PubMed ID: 31135920
[TBL] [Abstract][Full Text] [Related]
12. Everolimus-induced activation of latent
Jeon SY; Yhim HY; Lee NR; Song EK; Kwak JY; Yim CY
Korean J Intern Med; 2017 Mar; 32(2):365-368. PubMed ID: 26837008
[No Abstract] [Full Text] [Related]
13. Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report.
Yaegashi H; Izumi K; Konaka H; Mizokami A; Namiki M
J Med Case Rep; 2015 Nov; 9():261. PubMed ID: 26582158
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
Yoshinaga A; Kamata S
Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
[TBL] [Abstract][Full Text] [Related]
15. Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program.
van den Eertwegh AJ; Karakiewicz P; Bavbek S; Rha SY; Bracarda S; Bahl A; Ou YC; Kim D; Panneerselvam A; Anak O; Grünwald V
Urology; 2013 Jan; 81(1):143-9. PubMed ID: 23273080
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.
Thiery-Vuillemin A; Theodore C; Jacobasch L; Schmitz J; Papandreou C; Guillot A; Emmanouilides C; Slimane K; Kelkouli N; Kim S; Nguyen Tan Hon T
Clin Genitourin Cancer; 2015 Jun; 13(3):231-8. PubMed ID: 25456838
[TBL] [Abstract][Full Text] [Related]
17. Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the US.
Pal SK; Jonasch E; Signorovitch JE; Reichmann WM; Li N; Liu Z; Perez JR; Vogelzang NJ
J Med Econ; 2016; 19(5):462-8. PubMed ID: 26652893
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Hoshi K; Kanbara T; Kawasaki Y; Ikeda Y; Namima T; Ohnuma T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1315-7. PubMed ID: 17687222
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Hepatitis B Virus Reactivation With Lamivudine in a Patient With Advanced Renal Cell Carcinoma Treated With Everolimus.
D'Aniello C; Maruzzo M; Basso U
Am J Ther; 2016; 23(1):e300-3. PubMed ID: 24368609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
